While blood transfusions have been reported to be effective for managing anemia and thrombocytopenia and recombinant thrombomodulin for treating DIC, the main principle of DIC management is the appropriate treatment of the causative disease (20, 21). This evidence concerns the gene THBD and Thrombocytopenia.